Back
John Hancock Preferred Income Fund III Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison
Buy
54
HPS
John Hancock Preferred Income Fund III
Last Price:
$14.41
Seasonality Move:
1.27%
Sell
45
DRUG
Bright Minds Biosciences, Inc.
Last Price:
$83.03
Seasonality Move:
-32.16%
Buy
54
John Hancock Preferred Income Fund III (HPS)
is a Buy
Is John Hancock Preferred Income Fund III a Buy, Sell or Hold?
-
The current John Hancock Preferred Income Fund III [HPS] share price is $14.41. The Score for HPS is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
HPS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Bright Minds Biosciences, Inc. (DRUG)
is a Sell
Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?
-
The current Bright Minds Biosciences, Inc. [DRUG] share price is $84.00. The Score for DRUG is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HPS Stock Price Chart
What is John Hancock Preferred Income Fund III's stock price today?
-
The John Hancock Preferred Income Fund III share price today is $14.41Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HPS is experiencing slight buying pressure.
DRUG Stock Price Chart
What is Bright Minds Biosciences, Inc.'s stock price today?
-
The Bright Minds Biosciences, Inc. share price today is $84.00The current trend is moderately bullish and DRUG is experiencing slight buying pressure.
HPS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 34.72 | Sell |
| Chaikin Money Flow: | 8579 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.46 - 14.92) | Sell |
| Bollinger Bands (100): | (14.63 - 15.39) | Sell |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.62 | Buy |
| Relative Strength Index (14 RSI): | 59.07 | Buy |
| Chaikin Money Flow: | 33362 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.54 - 84.42) | Buy |
| Bollinger Bands (100): | (42.05 - 69.99) | Buy |
HPS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.41 | Buy |
| 20-day SMA: | 14.63 | Sell |
| 50-day SMA: | 15.03 | Sell |
| 200-day SMA: | 14.7 | Sell |
| 8-day EMA: | 14.43 | Sell |
| 20-day EMA: | 14.62 | Sell |
| 50-day EMA: | 14.61 | Sell |
| 200-day EMA: | 9.53 | Buy |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 86.03 | Sell |
| 20-day SMA: | 76.76 | Buy |
| 50-day SMA: | 66.5 | Buy |
| 200-day SMA: | 43.27 | Buy |
| 8-day EMA: | 83.84 | Buy |
| 20-day EMA: | 77.9 | Buy |
| 50-day EMA: | 68.05 | Buy |
| 200-day EMA: | 47.98 | Buy |
John Hancock Preferred Income Fund III Earnings Growth & HPS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.
John Hancock Preferred Income Fund III Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||